{"id":13152,"date":"2024-01-18T15:44:27","date_gmt":"2024-01-18T18:44:27","guid":{"rendered":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/"},"modified":"2024-01-18T15:44:27","modified_gmt":"2024-01-18T18:44:27","slug":"eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services","status":"publish","type":"post","link":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/","title":{"rendered":"ELIQUENT Life Sciences anuncia a aquisi\u00e7\u00e3o de um parceiro regulat\u00f3rio focado na Europa: RApport Global Strategic Services"},"content":{"rendered":"<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA ELIQUENT Life Sciences (ELIQUENT), firma global de consultoria regulat\u00f3ria para o setor de ci\u00eancias biol\u00f3gicas, anunciou hoje a aquisi\u00e7\u00e3o da RApport Global Strategic Services (RApport). A RApport \u00e9 uma empresa internacional de consultoria regulat\u00f3ria localizada no Reino Unido que apoia inovadores em ci\u00eancias biol\u00f3gicas obtendo e mantendo autoriza\u00e7\u00e3o para produtos mundialmente. A aquisi\u00e7\u00e3o da RApport pela ELIQUENT representa um importante passo no crescimento internacional da empresa e dos recursos expandidos na Europa.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA expertise europeia da RApport expande o alcance geogr\u00e1fico da ELIQUENT e oferece um portf\u00f3lio din\u00e2mico dos servi\u00e7os globais de consultoria regulat\u00f3ria. Os recursos combinados da ELIQUENT e da RApport permitem solu\u00e7\u00f5es regulat\u00f3rias de ponta a ponta criadas para otimizar as estrat\u00e9gias de desenvolvimento, entrada no mercado e conformidade em mercados globais.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n&#8220;O an\u00fancio hoje ainda posiciona a ELIQUENT como l\u00edder na \u00e1rea de consultoria regulat\u00f3ria global e ressalta nosso compromisso com fornecer valor aos nossos clientes&#8221;, afirmou Tim Dietlin, CEO da ELIQUENT Life Sciences. &#8220;Estou na expectativa da parceria com a talentosa equipe da RApport&agrave;medida que oferecemos aos nossos clientes um portf\u00f3lio de solu\u00e7\u00f5es criadas para otimizar as estrat\u00e9gias de entrada no mercado e conformidade mundialmente&#8221;.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\n&#8220;Com a integra\u00e7\u00e3o da RApport com a ELIQUENT, estamos criando uma sinergia poderosa na arena regulat\u00f3ria global, misturando nossa expertise europeia com recursos extensivos da ELIQUENT nos EUA e na \u00c1sia-Pac\u00edfico&#8221;, acrescentou Iftikhar Saiyed, Co-CEO da RApport. Lorna Griffin, Co-CEO da RApport, tamb\u00e9m acrescentou: &#8220;Esta parceria expande nossa habilidade de fornecer solu\u00e7\u00f5es regulat\u00f3rias abrangentes para o setor de ci\u00eancias biol\u00f3gicas&#8221;.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA RApport foi assessorada pela BDO LLP e pela Simons Muirhead Burton LLP, com aconselhamento estrat\u00e9gico suplementar da Indus Valley Advisors. A ELIQUENT e a GHO Capital foram assessoradas pela Slaughter and May, e pela Deloitte LLP.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><span class=\"bwuline\">Sobre a RApport<\/span><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA RApport Global Strategic Services \u00e9 uma empresa internacional especialista em consultoria regulat\u00f3ria que fornece apoio regulat\u00f3rio para as ind\u00fastrias farmac\u00eautica, biotecnol\u00f3gica e de dispositivos m\u00e9dicos. A equipe da RApport inclui especialistas com bastante experi\u00eancia na \u00e1rea regulat\u00f3ria e amplo conhecimento das vias regulat\u00f3rias internacionais. Entre as solu\u00e7\u00f5es globais da empresa est\u00e3o orienta\u00e7\u00e3o estrat\u00e9gica e t\u00e9cnica em programas de desenvolvimento, envio de documentos para fins regulat\u00f3rios, suporte p\u00f3s-comercializa\u00e7\u00e3o e muito mais.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><span class=\"bwuline\">Sobre a ELIQUENT<\/span><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA ELIQUENT Life Sciences \u00e9 a fus\u00e3o de cinco empresas globais de consultoria regulat\u00f3ria: <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcheckpoint.url-protection.com%2Fv1%2Furl%3Fo%3Dhttp%253A%2F%2Fwww.validant.com%2F%26g%3DMjJiNWI5YzdmZmE2MDc1OA%3D%3D%26h%3DNGM1MmFhMTk3NGUwY2ZkNTJmN2EwZGZmMjBkMjBjYWZjMmJiZmFiM2ZjZWU3ZDE4OGJhMWQ0N2VlMjMwNzkxMg%3D%3D%26p%3DYzJlOmdob2NhcGl0YWxsbHA6YzpvOjUxYzJiMmJlOGMzYzcwNWYyM2Y3YjliMTAxOGZjODcxOnYxOnA6Rg%3D%3D&amp;esheet=53884263&amp;newsitemid=20240118010872&amp;lan=pt-BR&amp;anchor=Validant&amp;index=1&amp;md5=43195d2f57210a05d550701c704d8b91\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">Validant<\/a>, <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcheckpoint.url-protection.com%2Fv1%2Furl%3Fo%3Dhttp%253A%2F%2Fwww.greenleafhealth.com%2F%26g%3DMTUwZDAyYTU4ODc3NjU5Mw%3D%3D%26h%3DNGY4Yjc5YTVlOThhZDFjNmIxNzc3MzNlZWYxOGY1ZDBhN2QzZWE3MjZmNDRjNWNiY2IzMWZlOTA2ZjExNjdjMg%3D%3D%26p%3DYzJlOmdob2NhcGl0YWxsbHA6YzpvOjUxYzJiMmJlOGMzYzcwNWYyM2Y3YjliMTAxOGZjODcxOnYxOnA6Rg%3D%3D&amp;esheet=53884263&amp;newsitemid=20240118010872&amp;lan=pt-BR&amp;anchor=Greenleaf+Health&amp;index=2&amp;md5=bd243f6a6885b3f64c242216148f8721\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">Greenleaf Health<\/a>, <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcheckpoint.url-protection.com%2Fv1%2Furl%3Fo%3Dhttp%253A%2F%2Fwww.data-revive.com%2F%26g%3DYTExZmVmNWI4Y2YyZDc1NA%3D%3D%26h%3DZGI2ZDMyNTk3NDU1ZmQxMTdhNDhjZTUxYjRiMDljZWQ3MmVlYzg0NTE5NzM3M2FhZDZiOTg4ZjE2ZmQ1MTY1Mw%3D%3D%26p%3DYzJlOmdob2NhcGl0YWxsbHA6YzpvOjUxYzJiMmJlOGMzYzcwNWYyM2Y3YjliMTAxOGZjODcxOnYxOnA6Rg%3D%3D&amp;esheet=53884263&amp;newsitemid=20240118010872&amp;lan=pt-BR&amp;anchor=DataRevive&amp;index=3&amp;md5=aaa0e63715606f6b4f272c617896d54e\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">DataRevive<\/a>, <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcheckpoint.url-protection.com%2Fv1%2Furl%3Fo%3Dhttp%253A%2F%2Fwww.orielstat.com%2F%26g%3DZDMxZmJlODY5ZWM3YTdhMA%3D%3D%26h%3DMmM2NzM2MTY3YzkxM2Q5Y2M4MjFlYjk5YzI4N2YyMDc2YTEzY2NkMmFmNDk5MTQwZjViMzNhMTgwNjQzMDdkZg%3D%3D%26p%3DYzJlOmdob2NhcGl0YWxsbHA6YzpvOjUxYzJiMmJlOGMzYzcwNWYyM2Y3YjliMTAxOGZjODcxOnYxOnA6Rg%3D%3D&amp;esheet=53884263&amp;newsitemid=20240118010872&amp;lan=pt-BR&amp;anchor=Oriel+Stat-a-Matrix&amp;index=4&amp;md5=b6c464a6865d38c353b570091a5c39d0\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">Oriel Stat-a-Matrix<\/a> e <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcheckpoint.url-protection.com%2Fv1%2Furl%3Fo%3Dhttp%253A%2F%2Fwww.idec-inc.com%2F%26g%3DNzMzZDU4NDE1ZTQ4MTE3Mg%3D%3D%26h%3DY2YzMjE0NDNlODcyOTM1OGZmMWIwNmU4NDMzYzlmOTQ2MTc5NDc0YjFlNDk2ZTkxMzk2MzJkMzk5MmRhNjY1Zg%3D%3D%26p%3DYzJlOmdob2NhcGl0YWxsbHA6YzpvOjUxYzJiMmJlOGMzYzcwNWYyM2Y3YjliMTAxOGZjODcxOnYxOnA6Rg%3D%3D&amp;esheet=53884263&amp;newsitemid=20240118010872&amp;lan=pt-BR&amp;anchor=IDEC&amp;index=5&amp;md5=aea392be03d753b9ad3e5269debfce38\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">IDEC<\/a>. Essa combina\u00e7\u00e3o sem precedentes de l\u00edderes na \u00e1rea regulat\u00f3ria, peritos do setor e especialistas t\u00e9cnicos facilita servi\u00e7os abrangentes que apoiam empresas farmac\u00eauticas, biotecnol\u00f3gicas e de dispositivos m\u00e9dicos ao navegarem o complexo cen\u00e1rio regulat\u00f3rio.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA acelerada estrat\u00e9gia de crescimento da ELIQUENT tem o suporte da GHO Capital, investidora europeia especialista em sa\u00fade. Em parceria com a ELIQUENT Life Sciences (anteriormente Validant) desde dezembro de 2018, o an\u00fancio realizado hoje segue a aquisi\u00e7\u00e3o da DataRevive em 2019, empresa de consultoria e estrat\u00e9gia regulat\u00f3ria para clientes globais; a aquisi\u00e7\u00e3o em novembro de 2020 da IDEC, empresa com lideran\u00e7a na \u00e1rea regulat\u00f3ria no Jap\u00e3o; a aquisi\u00e7\u00e3o em dezembro de 2020 da Oriel STAT A MATRIX, empresa de consultoria global e firma de treinamento para a ind\u00fastria de dispositivos m\u00e9dicos; e a aquisi\u00e7\u00e3o em abril de 2021 da Greenleaf Health, firma l\u00edder em consultoria regulat\u00f3ria da FDA.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><span class=\"bwuline\">Sobre a GHO<\/span><\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nA Global Healthcare Opportunities, ou GHO Capital Partners LLP, \u00e9 consultora l\u00edder especializada em investimentos no setor de sa\u00fade com sede em Londres. Aplicamos recursos e perspectivas globais para desbloquear oportunidades de sa\u00fade de alto crescimento, visando a internacionaliza\u00e7\u00e3o pan-europeia e transatl\u00e2ntica para a constru\u00e7\u00e3o de neg\u00f3cios l\u00edderes no mercado de valor estrat\u00e9gico global. Nosso hist\u00f3rico de investimentos comprovado reflete a profundidade inigual\u00e1vel de nossa experi\u00eancia no setor e nossa rede\u200b. Fazemos parcerias com equipes de gest\u00e3o s\u00f3lidas para gerar valor sustent\u00e1vel de longa dura\u00e7\u00e3o, melhorando a efici\u00eancia da presta\u00e7\u00e3o de cuidados de sa\u00fade para possibilitar cuidados de sa\u00fade melhores, mais r\u00e1pidos e mais acess\u00edveis. Para mais informa\u00e7\u00f5es, acesse <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcheckpoint.url-protection.com%2Fv1%2Furl%3Fo%3Dhttps%253A%2F%2Fwww.ghocapital.com%2F%26g%3DNDBkMzJiYmJjYjUzMWY4ZA%3D%3D%26h%3DNmM4MzIzNmFkNzc2NDEwZDhmYjYyNmNhNjg2MDI2ZDk5MTRmZDhiMmVlNDE1Yzk4ZmE5NDIwOGE2OGY0ZDI0Nw%3D%3D%26p%3DYzJlOmdob2NhcGl0YWxsbHA6YzpvOjUxYzJiMmJlOGMzYzcwNWYyM2Y3YjliMTAxOGZjODcxOnYxOnA6Rg%3D%3D&amp;esheet=53884263&amp;newsitemid=20240118010872&amp;lan=pt-BR&amp;anchor=www.ghocapital.com&amp;index=6&amp;md5=d55d34c2b808eb5dad4b02315c6d0391\" rel=\"nofollow noopener\" shape=\"rect\" target=\"_blank\">www.ghocapital.com<\/a>.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\">\nO texto no idioma original deste an\u00fancio \u00e9 a vers\u00e3o oficial autorizada. As tradu\u00e7\u00f5es s\u00e3o fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que \u00e9 a \u00fanica vers\u00e3o do texto que tem efeito legal.<\/p>\n<p xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240118010872r1&amp;sid=brdno&amp;distro=ftp\"><span class=\"bwct31415\"><\/span><\/p>\n<p id=\"mmgallerylink\" xmlns=\"http:\/\/www.w3.org\/1999\/xhtml\"><span id=\"mmgallerylink-phrase\">Ver a vers\u00e3o original em businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20240118010872\/pt\/\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.businesswire.com\/news\/home\/20240118010872\/pt\/<\/a><\/span><\/p>\n<p><b>Contato:<\/b><\/p>\n<p>\nTaryn Fritz Walpole\n<\/p>\n<p><a href=\"mailto:twalpole@eliquent.com\" rel=\"nofollow\" shape=\"rect\">twalpole@eliquent.com<br \/>\n<\/a><\/p>\n<p>202-445-7679<\/p>\n<p><strong>Fonte: <\/strong><a href='http:\/\/www.businesswire.com\/portal\/site\/home\/' target='_blank' rel=\"noopener\">BUSINESS WIRE<\/a><img src='https:\/\/api.dino.com.br\/v2\/news\/tr\/300524?partnerId=3197' alt=\"\" style=\"border:0px;width:1px;height:1px;\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A ELIQUENT Life Sciences (ELIQUENT), firma global de consultoria regulat\u00f3ria para o setor de ci\u00eancias biol\u00f3gicas, anunciou hoje a aquisi\u00e7\u00e3o da RApport Global Strategic Services (RApport). A RApport \u00e9 uma empresa internacional de consultoria regulat\u00f3ria localizada no Reino Unido que apoia inovadores em ci\u00eancias biol\u00f3gicas obtendo e mantendo autoriza\u00e7\u00e3o para produtos mundialmente. A aquisi\u00e7\u00e3o da [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-13152","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ELIQUENT Life Sciences anuncia a aquisi\u00e7\u00e3o de um parceiro regulat\u00f3rio focado na Europa: RApport Global Strategic Services - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ELIQUENT Life Sciences anuncia a aquisi\u00e7\u00e3o de um parceiro regulat\u00f3rio focado na Europa: RApport Global Strategic Services - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"og:description\" content=\"A ELIQUENT Life Sciences (ELIQUENT), firma global de consultoria regulat\u00f3ria para o setor de ci\u00eancias biol\u00f3gicas, anunciou hoje a aquisi\u00e7\u00e3o da RApport Global Strategic Services (RApport). A RApport \u00e9 uma empresa internacional de consultoria regulat\u00f3ria localizada no Reino Unido que apoia inovadores em ci\u00eancias biol\u00f3gicas obtendo e mantendo autoriza\u00e7\u00e3o para produtos mundialmente. A aquisi\u00e7\u00e3o da [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/\" \/>\n<meta property=\"og:site_name\" content=\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-18T18:44:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240118010872r1&amp;sid=brdno&amp;distro=ftp\" \/>\n<meta name=\"author\" content=\"DINO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"DINO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\\\/\"},\"author\":{\"name\":\"DINO\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"headline\":\"ELIQUENT Life Sciences anuncia a aquisi\u00e7\u00e3o de um parceiro regulat\u00f3rio focado na Europa: RApport Global Strategic Services\",\"datePublished\":\"2024-01-18T18:44:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\\\/\"},\"wordCount\":825,\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20240118010872r1&amp;sid=brdno&amp;distro=ftp\",\"articleSection\":[\"Not\u00edcias Corporativas\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\\\/\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\\\/\",\"name\":\"ELIQUENT Life Sciences anuncia a aquisi\u00e7\u00e3o de um parceiro regulat\u00f3rio focado na Europa: RApport Global Strategic Services - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20240118010872r1&amp;sid=brdno&amp;distro=ftp\",\"datePublished\":\"2024-01-18T18:44:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20240118010872r1&amp;sid=brdno&amp;distro=ftp\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20240118010872r1&amp;sid=brdno&amp;distro=ftp\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ELIQUENT Life Sciences anuncia a aquisi\u00e7\u00e3o de um parceiro regulat\u00f3rio focado na Europa: RApport Global Strategic Services\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#website\",\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/\",\"name\":\"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios\",\"description\":\"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/#\\\/schema\\\/person\\\/24f7b50e924d81f1023b69582993c0ff\",\"name\":\"DINO\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g\",\"caption\":\"DINO\"},\"url\":\"https:\\\/\\\/ocanal.com\\\/noticias\\\/corporativas\\\/author\\\/dino\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ELIQUENT Life Sciences anuncia a aquisi\u00e7\u00e3o de um parceiro regulat\u00f3rio focado na Europa: RApport Global Strategic Services - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/","og_locale":"pt_BR","og_type":"article","og_title":"ELIQUENT Life Sciences anuncia a aquisi\u00e7\u00e3o de um parceiro regulat\u00f3rio focado na Europa: RApport Global Strategic Services - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","og_description":"A ELIQUENT Life Sciences (ELIQUENT), firma global de consultoria regulat\u00f3ria para o setor de ci\u00eancias biol\u00f3gicas, anunciou hoje a aquisi\u00e7\u00e3o da RApport Global Strategic Services (RApport). A RApport \u00e9 uma empresa internacional de consultoria regulat\u00f3ria localizada no Reino Unido que apoia inovadores em ci\u00eancias biol\u00f3gicas obtendo e mantendo autoriza\u00e7\u00e3o para produtos mundialmente. A aquisi\u00e7\u00e3o da [&hellip;]","og_url":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/","og_site_name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","article_published_time":"2024-01-18T18:44:27+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240118010872r1&amp;sid=brdno&amp;distro=ftp","type":"","width":"","height":""}],"author":"DINO","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"DINO","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/#article","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/"},"author":{"name":"DINO","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"headline":"ELIQUENT Life Sciences anuncia a aquisi\u00e7\u00e3o de um parceiro regulat\u00f3rio focado na Europa: RApport Global Strategic Services","datePublished":"2024-01-18T18:44:27+00:00","mainEntityOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/"},"wordCount":825,"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240118010872r1&amp;sid=brdno&amp;distro=ftp","articleSection":["Not\u00edcias Corporativas"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/","url":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/","name":"ELIQUENT Life Sciences anuncia a aquisi\u00e7\u00e3o de um parceiro regulat\u00f3rio focado na Europa: RApport Global Strategic Services - Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","isPartOf":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/#primaryimage"},"image":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240118010872r1&amp;sid=brdno&amp;distro=ftp","datePublished":"2024-01-18T18:44:27+00:00","author":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff"},"breadcrumb":{"@id":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240118010872r1&amp;sid=brdno&amp;distro=ftp","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20240118010872r1&amp;sid=brdno&amp;distro=ftp"},{"@type":"BreadcrumbList","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/eliquent-life-sciences-anuncia-a-aquisicao-de-um-parceiro-regulatorio-focado-na-europa-rapport-global-strategic-services\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ocanal.com\/noticias\/corporativas\/"},{"@type":"ListItem","position":2,"name":"ELIQUENT Life Sciences anuncia a aquisi\u00e7\u00e3o de um parceiro regulat\u00f3rio focado na Europa: RApport Global Strategic Services"}]},{"@type":"WebSite","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#website","url":"https:\/\/ocanal.com\/noticias\/corporativas\/","name":"Ocanal Not\u00edcias Corporativas - Empresariais, comunicados e neg\u00f3cios","description":"Tudo sobre o mercado empresarial, comunicados e neg\u00f3cios","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ocanal.com\/noticias\/corporativas\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/ocanal.com\/noticias\/corporativas\/#\/schema\/person\/24f7b50e924d81f1023b69582993c0ff","name":"DINO","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ca8348556b3dfd41c825da9ac5643583f369a1092022fb6057420d716f02be0c?s=96&d=mm&r=g","caption":"DINO"},"url":"https:\/\/ocanal.com\/noticias\/corporativas\/author\/dino\/"}]}},"_links":{"self":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/13152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/comments?post=13152"}],"version-history":[{"count":0,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/posts\/13152\/revisions"}],"wp:attachment":[{"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/media?parent=13152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/categories?post=13152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ocanal.com\/noticias\/corporativas\/wp-json\/wp\/v2\/tags?post=13152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}